Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells

Niwa, 2005, Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma, Oncogene, 24, 6406, 10.1038/sj.onc.1208788

Lacronique, 1997, A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia, Science, 278, 1309, 10.1126/science.278.5341.1309

Zhang, 2003, Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells, Oncogene, 22, 894, 10.1038/sj.onc.1206158

Alvarez, 2006, Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor, Cancer Res, 66, 3162, 10.1158/0008-5472.CAN-05-3757

Shen, 2001, Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1, Proc Natl Acad Sci USA, 98, 1543, 10.1073/pnas.98.4.1543

Zamo, 2002, Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death, Oncogene, 21, 1038, 10.1038/sj.onc.1205152

Grandis, 2000, Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo, Proc Natl Acad Sci USA, 97, 4227, 10.1073/pnas.97.8.4227

Blaskovich, 2003, Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice, Cancer Res, 63, 1270

Yamashita, 2003, Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells, Oncogene, 22, 1638, 10.1038/sj.onc.1206277

Kanai, 2003, Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway, Oncogene, 22, 548, 10.1038/sj.onc.1206109

Mora, 2002, Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells, Cancer Res, 62, 6659

Buettner, 2002, Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention, Clin Cancer Res, 8, 945

Yu, 1995, Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein, Science, 269, 81, 10.1126/science.7541555

Ram, 2000, Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Gao protein, Science, 287, 142, 10.1126/science.287.5450.142

Maurer, 2007, Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer, Clin Cancer Res, 13, 1123, 10.1158/1078-0432.CCR-06-1668

Caron, 2005, Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival, Mol Cancer Ther, 4, 257, 10.1158/1535-7163.257.4.2

Lyall, 2006, Profiling markers of prognosis in colorectal cancer, Clin Cancer Res, 12, 1184, 10.1158/1078-0432.CCR-05-1864

Kaspar, 2007, The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis, Cancer Res, 67, 4940, 10.1158/0008-5472.CAN-07-0283

Schmelz, 2007, Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein, Cancer Res, 67, 5389, 10.1158/0008-5472.CAN-07-0536

Galizia, 2007, Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer, Oncogene, 26, 3654, 10.1038/sj.onc.1210381

Dambacher, 2007, Interleukin-31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is up-regulated in inflammatory bowel disease, Gut, 56, 1257, 10.1136/gut.2006.118679

Spano, 2006, JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications, Eur J Cancer, 42, 2668, 10.1016/j.ejca.2006.07.006

Ma, 2004, Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma, World J Gastroenterol, 10, 1569, 10.3748/wjg.v10.i11.1569

Lassmann, 2007, STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation, J Clin Pathol, 60, 173, 10.1136/jcp.2005.035113

Lu, 2007, Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells, J Biol Chem, 282, 12249, 10.1074/jbc.M608525200

Morita, 2000, Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts, Proc Natl Acad Sci USA, 97, 5405, 10.1073/pnas.090084797

Wang, 2005, AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec, Proc Natl Acad Sci USA, 102, 1104, 10.1073/pnas.0408831102

Hecht, 2004, Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas, Cancer Res, 64, 6109, 10.1158/0008-5472.CAN-04-1014

Yamabuki, 2007, Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas, Cancer Res, 67, 2517, 10.1158/0008-5472.CAN-06-3369

Oving, 2002, Molecular causes of colon cancer, Eur J Clin Invest, 32, 448, 10.1046/j.1365-2362.2002.01004.x

Bromberg, 1999, Stat3 as an oncogene, Cell, 98, 295, 10.1016/S0092-8674(00)81959-5

Li, 2002, Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines, J Biol Chem, 277, 17397, 10.1074/jbc.M109962200

Amin, 2003, Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma, Oncogene, 22, 5399, 10.1038/sj.onc.1206849

Saxena, 2007, Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells, Cancer Res, 67, 2497, 10.1158/0008-5472.CAN-06-3075

Pecquet, 2007, The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation, Oncogene, 26, 1577, 10.1038/sj.onc.1209949

Walker, 2007, STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas, Oncogene, 26, 224, 10.1038/sj.onc.1209775

Kusaba, 2005, Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors, J Clin Pathol, 58, 833, 10.1136/jcp.2004.023416

Kusaba, 2006, Activation of STAT3 is a marker of poor prognosis in human colorectal cancer, Oncol Rep, 15, 1445

Mahboubi, 2001, Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway, Lab Invest, 81, 327, 10.1038/labinvest.3780241

Aoki, 2003, Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma, Blood, 101, 1535, 10.1182/blood-2002-07-2130

Fornaro, 2003, Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway, J Biol Chem, 278, 50402, 10.1074/jbc.M307627200

Kunnumakkara, 2007, Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis, Blood, 109, 5112, 10.1182/blood-2007-01-067256

Tung-Ping Poon, 2000, Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma, Ann Surg, 232, 10, 10.1097/00000658-200007000-00003

Renne, 2007, High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma, Leukemia, 21, 780, 10.1038/sj.leu.2404594

Mottok, 2007, Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6, Blood, 10, 3387, 10.1182/blood-2007-03-082511